Crocs, Inc.
CROX
$100.14
-2.32%
Crocs, Inc. is a global footwear company engaged in the design, development, marketing, and sale of casual lifestyle footwear and accessories for men, women, and children, operating primarily in the Apparel - Footwear & Accessories industry. The company has established a distinct identity as a market leader in casual comfort footwear, anchored by its iconic clog, and has expanded its portfolio through the acquisition of the HEYDUDE brand. The current investor narrative is dominated by the company's recent earnings beat and a focused strategy to revitalize the underperforming HEYDUDE brand, which has sparked a significant rally in the stock as the market assesses the potential for a successful turnaround and margin recovery.…
CROX
Crocs, Inc.
$100.14
Related headlines
Investment Opinion: Should I buy CROX Today?
Rating & Thesis: Hold. Crocs presents a high-risk, high-potential-reward turnaround story that is too early to call, with the recent powerful rally having captured much of the near-term optimism. The stock is best suited for risk-tolerant investors who can stomach high volatility (beta 1.54) while awaiting concrete evidence of the HEYDUDE revitalization.
Supporting Evidence: The primary valuation metric, a forward P/E of 7.20, is exceptionally low and suggests the market expects minimal growth. The Price-to-Sales ratio of 1.15 is near the bottom of its historical range, indicating depressed sentiment. Positively, the company generates robust free cash flow ($659.2M TTM) and maintained a solid Q4 gross margin of 54.68%. However, these are counterbalanced by recent revenue declines (-3.25% YoY) and TTM net losses.
Risks & Conditions: The two biggest risks are the failure of the HEYDUDE turnaround and a re-acceleration of revenue declines in the core brand. This Hold rating would upgrade to a Buy if the company demonstrates two consecutive quarters of sequential HEYDUDE margin improvement and a return to positive YoY consolidated revenue growth. It would downgrade to a Sell if HEYDUDE's losses widen or if the stock fails to hold above key technical support near $90 after the post-earnings excitement fades. Based on current data, the stock appears fairly valued, pricing in both the significant cash flow and the substantial execution risks.
Sign up to view all
CROX 12-Month Price Forecast
The outlook for Crocs is a coin-flip heavily weighted by the success of a single initiative. The recent 28% monthly rally has likely front-run the initial good news, leaving the stock in a 'show me' phase. The low valuation and strong cash flow provide a tangible floor, but the ceiling is capped until HEYDUDE demonstrates sustained improvement. The stance is neutral due to the balanced risk/reward at current levels; it would turn bullish on evidence of successful HEYDUDE execution and bearish on a breakdown of post-earnings support levels.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Crocs, Inc.'s 12-month outlook, with a consensus price target around $130.18 and implied upside of +30.0% versus the current price.
Average Target
$130.18
3 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
3
covering this stock
Price Range
$80 - $130
Analyst target range
Analyst coverage for Crocs is limited, with only 3 analysts providing estimates, indicating this is a stock with less institutional scrutiny which can lead to higher volatility and less efficient price discovery. The estimated EPS range for these analysts is $14.48 to $15.26, with an average of $14.83, and the estimated revenue range is $4.48 billion to $4.66 billion, averaging $4.56 billion, but no consensus price target or recommendation data is provided in the dataset. The wide dispersion in revenue and EPS estimates, coupled with the minimal number of analysts, signals high uncertainty and a lack of strong consensus on the company's future trajectory, making the stock's path highly dependent on execution against its stated turnaround plan.
Bulls vs Bears: CROX Investment Factors
The investment debate for Crocs centers on a compelling value proposition versus significant execution risk. The bull case, currently supported by stronger short-term evidence from the powerful post-earnings rally, is anchored in deep-value valuation (forward P/E of 7.2), exceptional cash generation, and a clear catalyst in the HEYDUDE turnaround plan. The bear case highlights the company's inconsistent fundamentals, with recent revenue declines and TTM net losses, and the unproven nature of the brand revitalization. The single most important tension is the resolution of the HEYDUDE turnaround. If successful, it could unlock substantial margin recovery and justify a higher valuation multiple. If it fails, the stock could re-test its lows as the core Crocs brand growth may not be sufficient to offset the drag.
Bullish
- Strong Cash Generation: Crocs generates robust free cash flow of $659.2 million TTM, providing ample liquidity to service its debt, fund operations, and execute share buybacks. This financial flexibility is a key strength, especially during a turnaround phase.
- Attractive Valuation Metrics: The stock trades at a low forward P/E of 7.2 and a Price-to-Sales ratio of 1.15, near the bottom of its multi-year historical range. This suggests the market has priced in significant pessimism, offering a potential value opportunity if execution improves.
- Powerful Short-Term Momentum: The stock is up 27.76% over the past month, significantly outperforming the S&P 500 by 19.06%. This rally, sparked by a positive Q4 2025 earnings report, indicates a strong reversal in market sentiment.
- Solid Core Brand Gross Margin: The company maintains a healthy gross margin, with the Q4 2025 figure at 54.68%. This demonstrates the underlying profitability and pricing power of the flagship Crocs brand, which generated $768.38 million in the quarter.
Bearish
- Inconsistent Revenue & Profitability: Recent quarterly revenue declined 3.25% YoY, and the TTM picture shows a net loss resulting in negative EPS of -$0.02 and a net margin of -2.01%. This highlights fundamental volatility and the challenge of returning to consistent growth.
- HEYDUDE Brand Drag & Integration Risk: The HEYDUDE segment remains a smaller, problematic division. Its underperformance was a primary cause of the significant Q2 2025 net loss of -$492.3 million, and the turnaround is not yet proven, posing a major execution risk.
- High Volatility & Market Sensitivity: With a beta of 1.539, Crocs is 54% more volatile than the market, amplifying both gains and losses. This high volatility, coupled with a 52-week range of $73.21 to $122.84, indicates a stock prone to sharp swings based on sentiment.
- Limited Analyst Coverage & High Uncertainty: Only 3 analysts provide estimates, and their revenue forecasts for the year range widely from $4.48B to $4.66B. This lack of consensus and institutional scrutiny suggests higher uncertainty and less efficient price discovery.
CROX Technical Analysis
The stock is in a pronounced recovery phase from a significant drawdown, trading at $102.32, which represents a gain of 27.76% over the past month but only a modest 3.64% increase over the past year. With a 52-week range of $73.21 to $122.84, the current price sits at approximately 58% of this range, indicating it has recovered from the lows but remains well below its previous highs, suggesting there is substantial room for further recovery if the recent positive catalysts hold. Recent momentum is exceptionally strong, with the stock up 27.76% over one month and 19.21% over three months, sharply diverging from its tepid one-year performance and signaling a powerful short-term reversal, likely driven by the positive Q4 2025 earnings report in mid-February; this is corroborated by a relative strength of +19.06 versus the S&P 500 over the same period. Key technical support is anchored at the 52-week low of $73.21, while major resistance lies at the 52-week high of $122.84; a sustained breakout above this level would confirm a full recovery narrative, while a failure and breakdown below recent lows could indicate the rally was fleeting. The stock's beta of 1.539 indicates it is approximately 54% more volatile than the broader market, which amplifies both upside potential and downside risk, a critical factor for risk-aware investors.
Beta
1.54
1.54x market volatility
Max Drawdown
-39.0%
Largest decline past year
52-Week Range
$73-$123
Price range past year
Annual Return
+4.2%
Cumulative gain past year
| Period | CROX Return | S&P 500 |
|---|---|---|
| 1m | +25.2% | +12.6% |
| 3m | +21.4% | +2.5% |
| 6m | +22.6% | +4.3% |
| 1y | +4.2% | +28.4% |
| ytd | +15.2% | +4.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CROX Fundamental Analysis
Revenue growth has been inconsistent, with the most recent quarterly revenue of $957.64 million representing a year-over-year decline of 3.25%, continuing a trend of deceleration from stronger growth in prior quarters; segment data shows the Crocs brand generated $768.38 million while HEYDUDE contributed $189.26 million, indicating the latter remains a smaller, problematic division. Profitability metrics are mixed, with the company reporting net income of $105.17 million and a solid gross margin of 54.68% for Q4 2025, but the trailing twelve-month picture is clouded by a significant net loss in Q2 2025 that resulted in a negative trailing EPS of -$0.02 and a net margin of -2.01%; however, the operating margin of 3.70% and the positive Q4 results suggest a path back to consistent profitability. The balance sheet shows moderate leverage with a debt-to-equity ratio of 1.25, but financial health is supported by robust cash generation, evidenced by a trailing twelve-month free cash flow of $659.2 million and a current ratio of 1.27, indicating the company generates ample cash to service debt, fund operations, and return capital to shareholders via buybacks.
Quarterly Revenue
$957640000.0B
2025-12
Revenue YoY Growth
-0.03%
YoY Comparison
Gross Margin
+0.54%
Latest Quarter
Free Cash Flow
$659200000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CROX Overvalued?
Given the trailing twelve-month net income is negative, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The stock trades at a trailing PS ratio of 1.15 and a forward PE (based on estimated EPS) of 7.20, with the vast gap between a negative trailing PE of -57.09 and a low forward PE signaling the market expects a sharp return to profitability. Compared to sector averages, the PS ratio of 1.15 appears modest, though direct industry comparison data is not provided in the valuation set; the forward PE of 7.20 suggests the market is pricing in very subdued growth expectations relative to its historical profile. Historically, the stock's own PS ratio has fluctuated significantly, from a low near 1.15 currently to highs above 14 in 2021; trading near the bottom of its multi-year historical PS range suggests the stock is priced for pessimism, offering a potential value opportunity if the HEYDUDE turnaround and core brand momentum prove successful.
PE
-57.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -3x~16x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
6.2x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Crocs faces significant financial risk from its inconsistent profitability, evidenced by a trailing twelve-month net margin of -2.01% and a negative EPS. The company carries moderate leverage with a debt-to-equity ratio of 1.25, though this is mitigated by strong free cash flow of $659.2 million. The primary operational risk is concentration in the success of the HEYDUDE turnaround; this brand's underperformance was the direct cause of a catastrophic Q2 2025 net loss of -$492.3 million, demonstrating how a single segment can severely impact overall results.
Market & Competitive Risks: The stock's high beta of 1.539 makes it highly sensitive to broader market downturns, which could compress its valuation multiple despite company-specific progress. Trading at a forward P/E of 7.2, the market is pricing in very subdued growth; however, failure to meet even these low expectations could trigger a re-rating. Competitive and fashion-risk is perennial in footwear, and any misstep in brand relevance for either Crocs or HEYDUDE could lead to rapid inventory issues and margin pressure.
Worst-Case Scenario: The worst-case scenario involves a complete failure of the HEYDUDE turnaround strategy, coupled with a slowdown in the core Crocs brand and a broader market sell-off. This could lead to consecutive earnings misses, analyst downgrades, and a loss of investor confidence. In this adverse scenario, the stock could realistically retreat to its 52-week low of $73.21, representing a downside of approximately -28% from the current price of $102.32. The historical max drawdown of -38.97% provides a precedent for such severe declines.
FAQ
The key risks are, in order of severity: 1) Execution Risk: The HEYDUDE turnaround could fail, as evidenced by its role in the Q2 2025 $492M net loss. 2) Financial Volatility: Inconsistent profitability (TTM net margin -2.01%) makes earnings forecasts unreliable. 3) Market Sensitivity: A high beta of 1.539 means the stock will fall sharply in a market downturn. 4) Competitive/Fashion Risk: The footwear market is fickle, and brand relevance can wane quickly, impacting growth and margins.
The 12-month forecast is bifurcated, with a 50% probability base case target of $100-$115, a 30% probability bull case target of $122-$135, and a 20% probability bear case target of $73-$90. The base case is most likely, assuming the HEYDUDE turnaround shows gradual progress and earnings meet the subdued analyst consensus of ~$14.83 EPS. The key assumption is that management's plan stabilizes the underperforming brand without a major setback, allowing the stock to trade on its cash flow and low valuation multiple.
CROX appears fairly valued relative to its current risk profile. Its forward P/E of 7.20 is very low, suggesting the market expects minimal growth and is skeptical of the turnaround. The Price-to-Sales ratio of 1.15 is near the bottom of its own historical range, indicating depressed sentiment. However, this 'cheapness' is justified by recent revenue declines and TTM net losses. The valuation implies the market is paying a fair price for a company with strong cash flow but significant operational challenges.
CROX is a speculative buy only for investors with a high risk tolerance and a long enough time horizon to weather volatility. The recent 28% rally has captured the initial optimism, making the near-term risk/reward less compelling. The stock trades at a very low forward P/E of 7.2, offering value if the HEYDUDE turnaround succeeds, but the downside risk to the 52-week low of $73.21 (-28%) is real if it fails. It could be a good buy on a pullback for those who believe in management's execution capabilities.
CROX is unsuitable for short-term trading due to its high volatility (beta 1.54) and binary dependence on quarterly execution updates. It is better suited for a long-term (2+ year) investment horizon, allowing time for the HEYDUDE turnaround plan to play out fully. The lack of a dividend means returns are solely based on price appreciation. Investors should be prepared to hold through significant volatility while monitoring operational milestones.